Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies

News provided by

May 20, 2015, 11:49 ET

DUBLIN, May 19, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/qfxkcq/global_cell) has announced the addition of the "Global Cell Therapy Market Outlook 2020 " report to their offering.

Utilization of cell therapy in tissue and regenerative medicine is expected to have huge marketing potential. Presently, there are no other options which could help in the growth of deregulated organs. Several therapeutic molecules are present in this segment but they are unable to form new tissue or sometimes organ transplant is required.

Cell therapies are becoming competent with time and their utilization in large number of indications have made them an indispensible part of pharmaceutical industry. Significant investments in research and development segment along with years of data are helping in introduction of innovative products. However, they are quite new for pharmaceutical industry and their long-term effect is not known. It may offer hindrance but their superior pharmacological efficacy is going to promote their usage across the globe. It is at nascent stages but holds promise for future generations which are expected to observe boost in cell therapy products. Glitches in manufacturing and large scale production are needed to be solved in coming years. Many significant results have been achieved due to which confidence of investors, investigators, physicians and patients have increased in cell therapies. All these development shows that cell therapeutics are expected to generate significant revenues across the globe.

Global Cell Therapy Market Outlook 2020 Report Highlights:

- Introduction & Classification of Cell Therapy
- Role of Stem Cells in Cell Therapy
- Global Cell Therapy Market Analysis
- Global Cell Therapy Clinical Pipeline by Country, Indication & Phase
- Marketed Cell Therapy Clinical Insight by Brand Name, Company & Indication
- Global Cell Therapy Clinical Pipeline: 262 Cell Therapies
- Marketed Cell Therapies: 13

Marketed Cell Therapy Clinical Insight by Brand Name, Company & Indication

- Adipose Stem Cell Therapy (Adipocell®)
- Allogeneic Cultured Keratinocytes & Fibroblasts (Gintuit®)
- Angiogenic Cell Precursor Therapy (VesCell)
- Autologous Chondrocyte Implantation (ChondroCelect®)
- Autologous Chondrocytes (BioCart)
- Autologous Cultured Chondrocyte Implant (Carticel®)
- Autologous Cultured Chondrocytes (Chondrotransplant® DISC)
- Matrix Characterised Autologous Cultured Chondrocytes (MACI)
- Azficel-T (Laviv®)
- Human Skin Replacement for Burns (CellSpray®)
- Leukocyte Cell Therapy (CureXcell)
- Sipuleucel-T (Provenge®)
- T-Lymphocyte Cell Therapy (Immuncell-LC®)

Companies Mentioned

- AlloCure
- Arteriocyte Medical Systems
- Athersys Inc.
- Baxter Healthcare Corporation
- Bone Therapeutics
- Celgene Corporation
- Cell Medica
- Cellerant Therapeutics
- FibrocellScinence
- Forticell Bioscience
- Genzyme Corporation
- Green Cross Cell
- Histogenics Corporation
- ISTO Technologies
- InnovacellBiotechnologie AG
- Intercytex
- Intrexon Corporation
- Macrocure
- Mesoblast
- Molmed
- Nuo Therapeutics Inc
- OmniCyte
- Opexa Therapeutics
- Organogenesis
- Pharmicell
- Stem Cell Inc.
- TCA Cellular Therapy
- Teva Pharmaceuticals
- Tigenix
- Vericel Corporation

For more information visit http://www.researchandmarkets.com/research/qfxkcq/global_cell